Stryker Gross Margin 2012-2026 | SYK
Current and historical gross margin for Stryker (SYK) over the last 10 years. The current gross profit margin for Stryker as of June 30, 2026 is %.
| Stryker Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $25.84B | $16.79B | 64.98% |
| 2026-03-31 | $25.27B | $16.13B | 63.83% |
| 2025-12-31 | $25.12B | $16.07B | 63.96% |
| 2025-09-30 | $24.38B | $15.61B | 64.03% |
| 2025-06-30 | $23.82B | $15.28B | 64.14% |
| 2025-03-31 | $23.22B | $14.85B | 63.96% |
| 2024-12-31 | $22.60B | $14.44B | 63.91% |
| 2024-09-30 | $21.97B | $13.97B | 63.57% |
| 2024-06-30 | $21.39B | $13.61B | 63.63% |
| 2024-03-31 | $20.96B | $13.38B | 63.80% |
| 2023-12-31 | $20.50B | $13.06B | 63.70% |
| 2023-09-30 | $19.89B | $12.59B | 63.32% |
| 2023-06-30 | $19.46B | $12.22B | 62.79% |
| 2023-03-31 | $18.95B | $11.86B | 62.58% |
| 2022-12-31 | $18.45B | $11.58B | 62.76% |
| 2022-09-30 | $17.95B | $11.39B | 63.44% |
| 2022-06-30 | $17.63B | $11.25B | 63.80% |
| 2022-03-31 | $17.43B | $11.19B | 64.22% |
| 2021-12-31 | $17.11B | $10.97B | 64.11% |
| 2021-09-30 | $16.67B | $10.64B | 63.83% |
| 2021-06-30 | $16.25B | $10.46B | 64.38% |
| 2021-03-31 | $14.72B | $9.24B | 62.75% |
| 2020-12-31 | $14.35B | $9.06B | 63.11% |
| 2020-09-30 | $14.22B | $9.04B | 63.59% |
| 2020-06-30 | $14.07B | $8.91B | 63.34% |
| 2020-03-31 | $14.96B | $9.74B | 65.15% |
| 2019-12-31 | $14.88B | $9.70B | 65.14% |
| 2019-09-30 | $14.55B | $9.45B | 64.95% |
| 2019-06-30 | $14.20B | $9.27B | 65.29% |
| 2019-03-31 | $13.88B | $9.08B | 65.47% |
| 2018-12-31 | $13.60B | $8.94B | 65.72% |
| 2018-09-30 | $13.28B | $8.72B | 65.71% |
| 2018-06-30 | $13.04B | $8.55B | 65.58% |
| 2018-03-31 | $12.73B | $8.35B | 65.62% |
| 2017-12-31 | $12.44B | $8.18B | 65.73% |
| 2017-09-30 | $12.13B | $8.03B | 66.23% |
| 2017-06-30 | $11.96B | $7.92B | 66.26% |
| 2017-03-31 | $11.79B | $7.77B | 65.97% |
| 2016-12-31 | $11.33B | $7.50B | 66.26% |
| 2016-09-30 | $10.88B | $7.23B | 66.42% |
| 2016-06-30 | $10.47B | $6.98B | 66.67% |
| 2016-03-31 | $10.06B | $6.74B | 67.01% |
| 2015-12-31 | $9.95B | $6.60B | 66.38% |
| 2015-09-30 | $9.85B | $6.50B | 66.01% |
| 2015-06-30 | $9.82B | $6.44B | 65.56% |
| 2015-03-31 | $9.75B | $6.38B | 65.44% |
| 2014-12-31 | $9.68B | $6.36B | 65.70% |
| 2014-09-30 | $9.53B | $6.23B | 65.39% |
| 2014-06-30 | $9.29B | $6.14B | 66.08% |
| 2014-03-31 | $9.14B | $6.07B | 66.45% |
| 2013-12-31 | $9.02B | $6.02B | 66.72% |
| 2013-09-30 | $8.89B | $6.02B | 67.72% |
| 2013-06-30 | $8.79B | $5.95B | 67.66% |
| 2013-03-31 | $8.69B | $5.90B | 67.94% |
| 2012-12-31 | $8.66B | $5.88B | 67.88% |
| 2012-09-30 | $8.53B | $5.76B | 67.47% |
| 2012-06-30 | $8.51B | $5.72B | 67.23% |
| 2012-03-31 | $8.45B | $5.62B | 66.51% |
| 2011-12-31 | $8.31B | $5.50B | 66.16% |
| 2011-09-30 | $8.09B | $5.39B | 66.66% |
| 2011-06-30 | $7.82B | $5.26B | 67.18% |
| 2011-03-31 | $7.54B | $5.14B | 68.23% |
| 2010-12-31 | $7.32B | $5.03B | 68.77% |
| 2010-09-30 | $7.16B | $4.91B | 68.52% |
| 2010-06-30 | $7.04B | $4.79B | 68.04% |
| 2010-03-31 | $6.92B | $4.67B | 67.51% |
| 2009-12-31 | $6.72B | $4.54B | 67.54% |
| 2009-09-30 | $6.61B | $4.46B | 67.53% |
| 2009-06-30 | $6.61B | $4.46B | 67.47% |
| 2009-03-31 | $6.69B | $4.54B | 67.88% |
| 2008-12-31 | $6.72B | $4.59B | 68.26% |
| 2008-09-30 | $6.66B | $4.56B | 68.46% |
| 2008-06-30 | $6.46B | $4.44B | 68.80% |
| 2008-03-31 | $6.21B | $4.28B | 68.98% |
| 2007-12-31 | $6.00B | $4.14B | 68.91% |
| 2007-09-30 | $5.68B | $3.95B | 69.57% |
| 2007-06-30 | $5.45B | $3.80B | 69.66% |
| 2007-03-31 | $5.25B | $3.65B | 69.46% |
| 2006-12-31 | $5.15B | $3.53B | 68.58% |
| 2006-09-30 | $4.83B | $3.38B | 69.96% |
| 2006-06-30 | $4.77B | $3.29B | 68.92% |
| 2006-03-31 | $4.73B | $3.22B | 68.02% |
| 2005-12-31 | $4.61B | $3.12B | 67.70% |
| 2005-09-30 | $4.75B | $3.06B | 64.51% |
| 2005-06-30 | $4.61B | $2.97B | 64.53% |
| 2005-03-31 | $4.43B | $2.86B | 64.43% |
| 2004-12-31 | $4.26B | $2.75B | 64.49% |
| 2004-09-30 | $4.11B | $2.65B | 64.61% |
| 2004-06-30 | $3.96B | $2.55B | 64.25% |
| 2004-03-31 | $3.81B | $2.43B | 63.83% |
| 2003-12-31 | $3.63B | $2.31B | 63.81% |
| 2003-09-30 | $3.45B | $2.19B | 63.37% |
| 2003-06-30 | $3.31B | $2.10B | 63.28% |
| 2003-03-31 | $3.16B | $2.00B | 63.34% |
| 2002-12-31 | $3.01B | $1.90B | 63.11% |
| 2002-09-30 | $2.89B | $1.83B | 63.08% |
| 2002-06-30 | $2.77B | $1.75B | 63.27% |
| 2002-03-31 | $2.67B | $1.69B | 63.08% |
| 2001-12-31 | $2.60B | $1.64B | 62.99% |
| 2001-09-30 | $2.50B | $1.59B | 63.58% |
| 2001-06-30 | $2.43B | $1.56B | 63.91% |
| 2001-03-31 | $2.36B | $1.52B | 64.25% |
| 2000-12-31 | $2.29B | $1.48B | 64.48% |
| 2000-09-30 | $2.24B | $1.42B | 63.55% |
| 2000-06-30 | $2.19B | $1.32B | 60.49% |
| 2000-03-31 | $2.14B | $1.22B | 56.88% |
| 1999-12-31 | $2.10B | $1.11B | 52.97% |
| 1999-09-30 | $1.87B | $0.95B | 50.72% |
| 1999-06-30 | $1.63B | $0.84B | 51.57% |
| 1999-03-31 | $1.37B | $0.74B | 53.61% |
| 1998-12-31 | $1.10B | $0.63B | 57.21% |
| 1998-09-30 | $1.04B | $0.61B | 58.88% |
| 1998-06-30 | $1.01B | $0.60B | 59.33% |
| 1998-03-31 | $0.99B | $0.59B | 59.66% |
| 1997-12-31 | $0.98B | $0.58B | 59.49% |
| 1997-09-30 | $0.97B | $0.56B | 57.48% |
| 1997-06-30 | $0.96B | $0.55B | 57.17% |
| 1997-03-31 | $0.93B | $0.53B | 56.97% |
| 1996-12-31 | $0.91B | $0.52B | 56.81% |
| 1996-09-30 | $0.89B | $0.52B | 58.25% |
| 1996-06-30 | $0.87B | $0.51B | 58.14% |
| 1996-03-31 | $0.88B | $0.51B | 57.65% |
| 1995-12-31 | $0.87B | $0.50B | 57.68% |
| 1995-09-30 | $0.85B | $0.49B | 57.91% |
| 1995-06-30 | $0.82B | $0.47B | 57.54% |
| 1995-03-31 | $0.75B | $0.43B | 57.03% |
| 1994-12-31 | $0.68B | $0.38B | 55.87% |
| 1994-09-30 | $0.62B | $0.34B | 54.66% |
| 1994-06-30 | $0.59B | $0.32B | 54.19% |
| 1994-03-31 | $0.57B | $0.31B | 53.94% |
| 1993-12-31 | $0.56B | $0.30B | 54.04% |
| 1993-09-30 | $0.54B | $0.29B | 53.87% |
| 1993-06-30 | $0.52B | $0.28B | 53.83% |
| 1993-03-31 | $0.50B | $0.27B | 53.71% |
| 1992-12-31 | $0.48B | $0.26B | 53.46% |
| 1992-09-30 | $0.45B | $0.24B | 53.13% |
| 1992-06-30 | $0.42B | $0.22B | 52.97% |
| 1992-03-31 | $0.39B | $0.21B | 52.67% |
| 1991-12-31 | $0.37B | $0.19B | 52.46% |
| 1991-09-30 | $0.34B | $0.18B | 52.19% |
| 1991-06-30 | $0.32B | $0.17B | 52.02% |
| 1991-03-31 | $0.30B | $0.16B | 52.33% |
| 1990-12-31 | $0.28B | $0.15B | 52.48% |
| 1990-09-30 | $0.26B | $0.14B | 52.65% |
| 1990-06-30 | $0.25B | $0.13B | 52.99% |
| 1990-03-31 | $0.24B | $0.13B | 52.50% |
| 1989-12-31 | $0.23B | $0.12B | 52.21% |
| 1989-09-30 | $0.21B | $0.11B | 52.34% |
| 1989-06-30 | $0.20B | $0.11B | 52.22% |
| 1989-03-31 | $0.19B | $0.10B | 52.63% |
| 1988-12-31 | $0.18B | $0.09B | 52.51% |
| 1988-09-30 | $0.17B | $0.09B | 52.38% |
| 1988-06-30 | $0.16B | $0.08B | 52.17% |
| 1988-03-31 | $0.15B | $0.08B | 51.95% |
| 1987-12-31 | $0.15B | $0.08B | 51.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $108.118B | $25.116B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| Haemonetics (HAE) | United States | $4.837B | 21.22 |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |